Zurich University Hospital Files Criminal Complaints Over Heart Surgery Scandal

Eleven lives lost and thirteen cases of medical device misuse have pushed the University Hospital Zurich (USZ) into a legal firestorm. The hospital’s own board has taken the unprecedented step of filing criminal complaints for involuntary manslaughter and grievous bodily harm. This is no longer just an internal administrative failure; it is a full-scale criminal investigation into the heart of Switzerland’s most prestigious medical institution. The move follows months of simmering tension after irregularities in the Clinic for Cardiac Surgery were first brought to light. While the hospital previously admitted to 'serious errors,' these formal complaints against persons unknown signal a dramatic shift toward accountability. The Zurich public prosecutor is now dismantling the wall of silence that often surrounds medical institutions, investigating not just clinical errors, but the potential for forgery of documents. This aggressive legal posture sends a clear message: the sanctity of the operating room does not grant immunity from the Swiss penal code.

A staggering 74 excess deaths haunt the records of the Zurich cardiac clinic. The 'Oberholzer report,' a damning independent audit published in early May, revealed that between 2016 and 2020, the clinic performed approximately 4,500 operations. Within this window, the mortality rate surpassed statistical expectations by a margin of 68 to 74 deaths. This is not a minor fluctuation; it is a systemic anomaly that demands an explanation. These figures represent fathers, mothers, and children whose outcomes deviated sharply from the high standards expected of Swiss healthcare. The report paints a grim picture of a department where the margin for error was consistently breached. While surgeons often deal with high-risk cases, the sheer volume of these 'unexpected' fatalities has provided the evidentiary backbone for the current criminal proceedings. Investigators are now tasked with determining whether these deaths were the tragic result of complex medicine or the criminal consequence of negligence and systemic malpractice.

Financial gain and medical ethics collided in a scandal that reaches the very top of the clinic’s former leadership. Francesco Maisano, the clinic’s former director, stands at the center of allegations involving a medical device he helped develop. Investigators are probing whether the use of this device was motivated by patient welfare or personal financial benefit. This potential conflict of interest is compounded by allegations of document forgery, suggesting a deliberate attempt to mask the reality of clinical outcomes. The betrayal of trust is twofold: patients believed they were receiving the best possible care, while the institution’s oversight mechanisms failed to detect the self-serving nature of these decisions. CEO Monika Jänicke has publicly thanked the whistleblower who broke the silence, a rare admission of the vital role internal dissent plays in maintaining institutional integrity. However, the damage to the hospital’s reputation is significant, as the investigation delves into how private profit could ever be allowed to influence the sterile environment of a heart surgery.

The Zurich Cantonal Prosecutor’s Office is not taking any chances, deploying a specialized 'strike team' of four elite prosecutors to lead the charge. This team brings together a formidable combination of expertise in medical criminal law, white-collar crime, and offenses involving public officials. Their presence underscores the gravity and complexity of the case, which spans thousands of pages of medical records and intricate financial trails. This is a clear signal that the state intends to pursue this investigation with surgical precision. As they establish whether sufficient evidence exists for formal indictments, the Swiss healthcare sector watches with bated breath. The outcome of this case will likely redefine the boundaries of medical liability and the transparency requirements for clinical directors across the country. For the families of the deceased, the wheels of justice are finally turning, but the process will be long. This investigation is a watershed moment for Swiss medicine, forcing a national reckoning over how the country’s most trusted institutions are governed and held to account.